SORCS3
Basic information
Region (hg38): 10:104641290-105265242
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SORCS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 60 | 67 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 60 | 7 | 9 |
Variants in SORCS3
This is a list of pathogenic ClinVar variants found in the SORCS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-104641362-G-A | Benign (Dec 31, 2019) | |||
10-104641386-C-G | not specified | Uncertain significance (Mar 11, 2024) | ||
10-104641421-G-A | Benign (Apr 05, 2018) | |||
10-104641442-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
10-104641461-G-A | not specified | Uncertain significance (May 25, 2022) | ||
10-104641464-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
10-104641479-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
10-104641565-G-C | not specified | Uncertain significance (Aug 09, 2021) | ||
10-104641577-C-A | SORCS3-related disorder | Likely benign (Apr 08, 2023) | ||
10-104641591-G-T | not specified | Uncertain significance (Dec 16, 2022) | ||
10-104641633-G-C | not specified | Uncertain significance (Feb 10, 2022) | ||
10-104641647-G-T | not specified | Uncertain significance (Nov 15, 2021) | ||
10-104641649-A-T | not specified | Uncertain significance (Nov 15, 2021) | ||
10-104641695-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
10-104641717-G-T | not specified | Uncertain significance (Apr 24, 2024) | ||
10-104641718-A-C | not specified | Uncertain significance (Apr 24, 2024) | ||
10-104641755-G-C | not specified | Uncertain significance (May 16, 2024) | ||
10-104641808-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
10-104641832-A-C | not specified | Uncertain significance (Nov 22, 2023) | ||
10-104641835-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
10-104641850-G-A | not specified | Uncertain significance (Dec 07, 2022) | ||
10-104641882-C-A | not specified | Uncertain significance (Feb 14, 2023) | ||
10-104641908-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
10-104641916-A-T | not specified | Uncertain significance (Nov 20, 2023) | ||
10-104641922-G-T | not specified | Uncertain significance (Jul 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SORCS3 | protein_coding | protein_coding | ENST00000369701 | 27 | 624135 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000374 | 1.00 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.52 | 542 | 651 | 0.832 | 0.0000345 | 7925 |
Missense in Polyphen | 119 | 191.75 | 0.62061 | 2386 | ||
Synonymous | -0.147 | 263 | 260 | 1.01 | 0.0000148 | 2423 |
Loss of Function | 4.98 | 20 | 62.5 | 0.320 | 0.00000300 | 741 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000334 | 0.000333 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.531
- rvis_EVS
- -1.17
- rvis_percentile_EVS
- 6.04
Haploinsufficiency Scores
- pHI
- 0.815
- hipred
- Y
- hipred_score
- 0.711
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.276
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sorcs3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- neuropeptide signaling pathway;learning;memory;regulation of long-term synaptic depression
- Cellular component
- membrane;glutamatergic synapse;integral component of postsynaptic density membrane
- Molecular function
- neuropeptide receptor activity